Unchained Labs crowns the Queen of stability characterization, launches Aunty!
January 13, 2025
Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched Aunty today – the fastest and highest throughput protein stability characterization tool in all the realm. Aunty bestows upon researchers all the thermal, colloidal and long-term stability data that their hearts desire and [...]
OmicsBox 3.4: CellKB’s Advanced Cell-Type Annotation
January 13, 2025
Improved Metagenomics Classification, and Enhanced Long-Read Transcriptomics Pipelines We proudly present the OmicsBox Version 3.4 release that introduces a range of enhancements designed to address the evolving needs of modern genomics and transcriptomics research. A key highlight of OmicsBox 3.4 is the integration of CellKB, a robust cell-type prediction tool for single-cell RNA sequencing (scRNA-Seq) [...]
January 13, 2025
Strategic collaboration will introduce AI-enabled tools, optimized data sharing, bring your own cloud (BYOC) support, and enhanced scalability NEWTON, Mass. -- The Broad Institute of MIT and Harvard today announced a strategic collaboration with Manifold, a leader in research infrastructure for biomedical science, to develop a cutting-edge research platform. This initiative expands on Broad's vision for biomedical data analysis, secure sharing, and global [...]
Synthego Signs Strategic Agreement with AstraZeneca to License CRISPR Gene Editing Enzyme
January 13, 2025
REDWOOD CITY, Calif. -- Synthego, a leading supplier of CRISPR solutions, has entered a strategic licensing agreement with global biopharmaceutical company AstraZeneca. This agreement grants Synthego a global license to manufacture and distribute AstraZeneca's novel CRISPR gene editing enzyme, eSpOT-ON, recently published as engineered ePsCas9, to the worldwide research community. This state-of-the-art nuclease, developed by AstraZeneca, will [...]
Simulations Plus Supported Development of Every FDA-Approved Drug in 2024
January 13, 2025
SLP’s technology and expertise accelerates drug development and supports critical advancements in global healthcare Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today highlighted its impact on the pharmaceutical industry through supporting the development of 100% of the drugs approved [...]
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9
January 13, 2025
The new Express License service removes barriers to accessing this transformative gene editing technology for startups. An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio through a non-exclusive internal research license. DUBLIN and CHESHIRE, United Kingdom -- ERS Genomics (‘ERS’), the CRISPR licensing company, today announces the launch of its [...]
Labviva Secures $25M to Accelerate Product Development and Global Expansion
January 13, 2025
Series B investment underscores high growth opportunity for AI in life sciences BOSTON — Labviva, the leading AI procurement platform for life sciences, today announced the close of its $25 million Series B, bringing its total funding to $55 million. Led by 53 Stations, with continued participation from Biospring Partners, B Capital Group, and Glasswing Ventures, the investment reflects the [...]
January 13, 2025
Monheim, Germany -- Cube Biotech and IBA Lifesciences, two leading innovators in the biotechnology industry, join forces to create a unified powerhouse dedicated to advancing research and production capabilities for the life science industry. The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization and to enable groundbreaking [...]
January 10, 2025
Cambridge, UK and Yokohama, Japan – Qkine Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, and REPROCELL Inc., Japan’s first and leading induced pluripotent stem cell (iPSC) company, have partnered to globally distribute high-quality proteins such as growth factors and cytokines manufactured by Qkine. Qkine has specialist expertise [...]
VELP Scientifica Receives Bronze Medal in EcoVadis Sustainability Rating
January 10, 2025
This recognition highlights VELP’s ongoing commitment to sustainability, encompassing environmental stewardship, ethical business practices, labor and human rights, and responsible procurement strategies. VELP Scientifica is proud to announce that it has been awarded the Bronze Medal from EcoVadis, a leading organization in sustainability performance ratings. With over 130,000 companies assessed worldwide, this acknowledgment underscores VELP’s dedication to improving its sustainability efforts. [...]

